# Nutrien Ltd. (NTR) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Construction Materials. Price $79.47, market value $37.9 billion.

## Valuation
- **P/E (trailing): 16.1×** (5-yr avg 16.3×, 3-yr avg 21.7×). Nutrien Ltd. trades at 16.1× trailing earnings, close to its own five-year average of 16.3×. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 16.2×, higher than trailing, so analysts expect earnings to fall.
- **PEG: 0.07**. A PEG of 0.07 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.3×**. Each dollar of revenue is priced at 1.3×.
- **Price / book: 1.5×**. The shares trade at 1.5× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 8.0×**. Enterprise value is 8.0× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 5.6%** (5-yr avg 8.9%). Free cash flow equals 5.6% of the market value, below its five-year average of 8.9%, so the shares are pricier on cash than usual. Above 5% is generally attractive.
- **Earnings yield: 6.2%**. The inverse of the P/E: 6.2% of the price is earned each year.

## Profitability
- **Gross margin: 31.0%**. Nutrien Ltd. keeps 31.0% of revenue after the direct cost of what it sells.
- **Operating margin: 14.2%**. 14.2% of revenue is left after running the business.
- **Net margin: 8.6%**. 8.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 9.1%**. 9.1% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 8.3%**. Return on all capital, debt included, is 8.3%.
- **Return on assets: 4.6%**. Each dollar of assets produces 4.6% of profit.

## Growth
- **Revenue growth (1 yr): 3.5%** (3-yr -10.8%/yr, 5-yr 5.2%/yr). Revenue grew 3.5% over the last year, against 5.2% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 248.5%** (3-yr -30.6%/yr, 5-yr 42.4%/yr). Earnings per share rose 248.5%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -28.9%/yr**. Free cash flow has compounded at -28.9% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.48**. Debt is 0.48 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 1.8×**. It would take 1.8 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 5.7×**. Operating profit covers interest 5.7× over, a safe margin.
- **Current ratio: 1.34** (quick 0.70). Current assets cover the next year's liabilities 1.34 times.
- **Altman Z-score: 2.35**. A Z-score of 2.35 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 8/9**. 8 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 2.77%** ($2.19 per share, trailing). Nutrien Ltd. yields 2.77%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 47%** (50% of free cash flow). 47% of earnings goes out as dividends, leaving room to keep raising it.
- **Dividend growth (5 yr): 2.3%/yr** (1-yr -6.6%). The dividend has grown 2.3% a year over five years.
- **Shareholder yield: 4.3%**. Dividends plus net buybacks return 4.3% of the market value a year.

## Analyst view
- **Analyst consensus: buy** (21 analysts). 21 analysts cover Nutrien Ltd.; the consensus is buy, with an average price target of $76.43 (-4% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 41.8%** (YTD 30.9%, 3-mo 19.3%). The shares are up 41.8% over twelve months including dividends.
- **From 52-week high: -6.9%** (49.9% above the low). Trading 7% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 71**. An RSI of 71 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): -0.10** (volatility 33%). Beta of -0.10 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=NTR · Page: https://foliofundamentals.com/stocks/ntr

Not investment advice.
